Nukkleus (NASDAQ:NUKK) vs. Genpact (NYSE:G) Head-To-Head Comparison

Genpact (NYSE:G) and Nukkleus (NASDAQ:NUKK) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability.

Volatility and Risk

Genpact has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Comparatively, Nukkleus has a beta of -0.36, suggesting that its stock price is 136% less volatile than the S&P 500.

Profitability

This table compares Genpact and Nukkleus’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Genpact	14.12%	22.28%	10.25%
Nukkleus	N/A	N/A	-608.22%

Earnings & Valuation

This table compares Genpact and Nukkleus”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$4.59 billion	1.51	$631.26 million	$3.50	11.02
Nukkleus	$10.75 million	0.03	-$17.43 million	N/A	N/A

Genpact has higher revenue and earnings than Nukkleus.

Insider and Institutional Ownership

96.0% of Genpact shares are owned by institutional investors. Comparatively, 12.5% of Nukkleus shares are owned by institutional investors. 2.8% of Genpact shares are owned by insiders. Comparatively, 69.8% of Nukkleus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Genpact and Nukkleus, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0	8	1	0	2.11
Nukkleus	0	0	0	0	N/A

Genpact presently has a consensus price target of $38.78, suggesting a potential upside of 0.56%. Given Genpact’s higher probable upside, equities research analysts plainly believe Genpact is more favorable than Nukkleus.

Summary

Genpact beats Nukkleus on 10 of the 11 factors compared between the two stocks.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.

About Nukkleus

Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. The company primarily offers software, technology, customer sales and marketing, and risk management technology hardware and software solutions. It also offers payment services from one fiat currency to another or to digital assets. The company was founded in 2013 and is headquartered in Jersey City, New Jersey. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd.